Aqr Capital Management LLC Lannett CO Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.28 - $9.64 $100,589 - $183,651	-19,051 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $852,454 - $1.06 Million	-148,253 Reduced 88.61%	19,051 $124,000
Q3 2020 Nov 16, 2020	SELL	$4.9 - $7.12 $238,443 - $346,473	-48,662 Reduced 22.53%	167,304 $1.02 Million
Q2 2020 Aug 17, 2020	SELL	$6.43 - $9.86 $83,172 - $127,539	-12,935 Reduced 5.65%	215,966 $1.57 Million
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $50,854 - $80,359	-7,996 Reduced 3.38%	228,901 $1.59 Million
Q4 2019 Feb 14, 2020	BUY	$8.49 - $12.81 $684,412 - $1.03 Million	80,614 Added 51.58%	236,897 $2.09 Million
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $450,239 - $1.17 Million	-80,688 Reduced 34.05%	156,283 $1.75 Million
Q2 2019 Aug 14, 2019	BUY	$5.22 - $9.08 $342,734 - $596,174	65,658 Added 38.33%	236,971 $1.44 Million
Q1 2019 May 14, 2019	SELL	$5.35 - $9.82 $964,423 - $1.77 Million	-180,266 Reduced 51.27%	171,313 $1.35 Million
Q4 2018 Feb 14, 2019	BUY	$3.43 - $6.19 $889,104 - $1.6 Million	259,214 Added 280.64%	351,579 $1.74 Million
Q3 2018 Nov 15, 2018	SELL	$4.75 - $14.5 $28,552 - $87,159	-6,011 Reduced 6.11%	92,365 $439,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $35,258 - $46,259	-2,651 Reduced 2.62%	98,376 $1.34 Million
Q1 2018 May 15, 2018	BUY	$14.7 - $24.95 $730,898 - $1.24 Million	49,721 Added 96.91%	101,027 $1.62 Million
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $166,045 - $244,062	8,344 Added 19.42%	51,306 $1.19 Million
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $648,726 - $827,018	42,962	42,962 $793,000

Others Institutions Holding LCI

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About LANNETT CO INC

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

More about LCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account